Task: Answer the multiple-choice question.
Query: Which compound exhibits a 12.033% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
[a] CN(CCN1CCOCC1)C(=O)CC1C(=O)NCCN1Cc1ccccc1F
[b] COc1ccc(/C=C/c2ccccc2)cc1[C@H]1[C@@H]2C=CCC[C@@]2(C)C(=O)N1Cc1ccccc1
Answer: a. CN(CCN1CCOCC1)C(=O)CC1C(=O)NCCN1Cc1ccccc1F
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN(CCN1CCOCC1)C(=O)CC1C(=O)NCCN1Cc1ccccc1F
CN(CCN1CCOCC1)C(=O)CC1C(=O)NCCN1Cc1ccccc1F
2-[1-[(2-fluorophenyl)methyl]-3-oxopiperazin-2-yl]-N-methyl-N-(2-morpholin-4-ylethyl)acetamide